CAS 2349386-89-4
:EIDD-2801
Description:
EIDD-2801, also known by its chemical name, is a small molecule that has garnered attention for its potential antiviral properties, particularly against RNA viruses, including coronaviruses. It functions as a nucleoside analog, which means it mimics the building blocks of RNA, thereby interfering with viral replication. This compound has shown promise in preclinical studies for its ability to inhibit viral polymerases, leading to reduced viral load in infected cells. EIDD-2801 is characterized by its ability to be orally bioavailable, making it a candidate for convenient administration in therapeutic settings. Its mechanism of action involves incorporation into viral RNA, resulting in mutations that hinder the virus's ability to replicate effectively. Additionally, the compound has been evaluated for safety and efficacy in various studies, highlighting its potential as a treatment option during viral outbreaks. As research continues, EIDD-2801 may contribute to the development of antiviral therapies, particularly in the context of emerging infectious diseases.
Formula:C13H19N3O7
Synonyms:- ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofurChemicalbookan-2-yl)methylisobutyrate
- Molnupiravir
- Molnupiravir(MK-4482)
- TUBE994
- Tube994
- EIDD-2801(Molnupiravir)
- EIDD-2801(EIDD 2801)
- ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
- Molnupiravir-001
- UNII-YA84KI1VEW
- Uridine, 4-oxime, 5'-(2-methylpropanoate)
- MolnupiravirEIDD-2801(API)
- β-D-N4 hydroxycytidine-5'-isopropyl ester
- ((2R,3S,4R,5R)-3,4-dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
- EIDD-2801
- EIDO-2801
- ((2R,3S,4R,5R)-3,4-dihydroxy-5-(4-(hydroxyamino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
CAS:Formula:C13H19N3O7Purity:97%Color and Shape:SolidMolecular weight:329.3059Ref: IN-DA01JNIM
1g28.00€5g56.00€1kgTo inquire25g122.00€5kgTo inquire100g343.00€100mg24.00€250mg24.00€EIDD-2801
CAS:<p>EIDD-2801 (Molnupiravir) is a prodrug for N 4-hydroxycytidine, effective against influenza and various coronaviruses.</p>Formula:C13H19N3O7Purity:99.7% - >99.99%Color and Shape:SolidMolecular weight:329.31Molnupiravir
CAS:Controlled Product<p>EIDD 2801 is an orally bioavailable prodrug of β-D-N4-hydroxycytidine and was shown to inhibit SARS-CoV-2 replication in human airway epithelial cells. EIDD 2801 was also tested in mice infected with SARS-CoV and MERS-CoV viruses. EIDD 2801 targets the RNA-dependent RNA polymerase (RdRp) and reduces virus titer and improved pulmonary function in experimental animals when used in prophylactic and therapeutic regime.</p>Formula:C13H19N3O7Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:329.31 g/molMolnupiravir - Bio-X ™
CAS:Controlled Product<p>EIDD 2801 is an orally bioavailable prodrug of β-D-N4-hydroxycytidine and was shown to inhibit SARS-CoV-2 replication in human airway epithelial cells. EIDD 2801 was also tested in mice infected with SARS-CoV and MERS-CoV viruses. EIDD 2801 targets the RNA-dependent RNA polymerase (RdRp) and reduces virus titer and improved pulmonary function in experimental animals when used in prophylactic and therapeutic regime.</p>Formula:C13H19N3O7Purity:Min. 95%Color and Shape:Clear LiquidMolecular weight:329.31 g/mol





